Literature DB >> 15853089

Exploratory study on end-of-life issues: barriers to palliative care and advance directives.

Veronica D Feeg1, Hoda Elebiary.   

Abstract

BACKGROUND: In the United States, as in most developed countries, death is rarely unexpected. It usually occurs in older persons with chronic progressive illnesses that often are complicated by infections or exacerbations. Many patients with terminal illnesses choose palliative care to relieve symptoms, improve the quality of their lives, and strive for a peaceful death. Professionals who serve dying patients need to recognize the importance of advance directives as part of a patient's decision to forgo curative treatment for palliative care.
OBJECTIVES: SOLACE (Supporters of Life-Affirming Care at End of Life) is a coalition of interdisciplinary professionals in the northern Virginia community dedicated to improving end-of-life care. The objectives of the SOLACE survey were to identify and describe: 1) professionals' perceptions about barriers related to hospice and palliative care, 2) professionals' opinions about barriers related to dying at home, 3) professionals' perceptions about barriers related to advance directives, and 4) relationships between professionals and their perceived barriers to advance directives and hospice and palliative care.
METHODS: From several consultations with hospice experts, a survey questionnaire was developed to solicit responses from professionals on palliative care, dying at home, and advance directives. Measures that assessed obstacles to palliative care were modified from previous studies to yield composite barrier scores. From a sample of a variety of participants at a national conference on palliative care (n = 200), 101 subjects returned questionnaires (51 percent) yielding 100 usable completed forms from attendees who demonstrated an interest in palliative care and, in some cases, a high level of personal or professional experience. Survey results were analyzed on respondents' perceptions concerning barriers related to advance directives and the delivery of palliative care.
RESULTS: Of the 13 obstacle statements, results show that respondents rated the top three barriers as 1) physician reluctance to make referrals (mean = 4.23), 2) physician lack of familiarity with availability and suitability of hospice (mean = 3.93), and 3) association of hospice with death (mean = 3.93). There was a statistically significant difference in scores for respondents from hospitals and respondents from hospices on their assessment of barriers for the association of hospice with death (t = -2.09, p < .05) and the lack of information about the severity of or irreversibility of the patients illness (t = -2.78, p < .01).

Entities:  

Mesh:

Year:  2005        PMID: 15853089     DOI: 10.1177/104990910502200207

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  20 in total

1.  Impact of palliative care consultative service on disease awareness for patients with terminal cancer.

Authors:  Wen-Chi Chou; Yu-Shin Hung; Chen-Yi Kao; Po-Jung Su; Chia-Hsun Hsieh; Jen-Shi Chen; Chi-Ting Liau; Yung-Chang Lin; Chuang-Chi Liaw; Hung-Ming Wang
Journal:  Support Care Cancer       Date:  2013-02-21       Impact factor: 3.603

2.  Utilization of supportive and palliative care services among oncology outpatients at one academic cancer center: determinants of use and barriers to access.

Authors:  Pallavi Kumar; David Casarett; Amy Corcoran; Krupali Desai; Qing Li; Jinbo Chen; Corey Langer; Jun J Mao
Journal:  J Palliat Med       Date:  2012-06-25       Impact factor: 2.947

3.  A Case Study of Hispanics and Hospice Care.

Authors:  Iraida V Carrion; Karen Bullock
Journal:  Int J Humanit Soc Sci       Date:  2012-02-01

4.  End-of-Life Medical Costs of Medicaid Cancer Patients.

Authors:  Florence K L Tangka; Sujha Subramanian; Susan A Sabatino; David H Howard; Susan Haber; Sonja Hoover; Lisa C Richardson
Journal:  Health Serv Res       Date:  2014-11-25       Impact factor: 3.402

5.  Barriers to referral to inpatient palliative care units in Japan: a qualitative survey with content analysis.

Authors:  Mitsunori Miyashita; Kei Hirai; Tatsuya Morita; Makiko Sanjo; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2007-02-21       Impact factor: 3.603

6.  Training mid-level providers on palliative care: bringing advanced directives and symptom assessment and management to community oncology practices.

Authors:  Mary Lesperance; Robert Shannon; Phyllis K Pumphrey; Erin Dunbar; Renee Genther; C Lynn Coleman; Margaret Tabano; Jennifer Maurer; Adrienne Vazquez; Elizabeth Capp; Jessica McMillan; Katie Wilkerson; Gerald Robbins; Dorothy Green Phillips; Priscilla Howick; Catherine Solaun; Jeff Sloan; Gerardo Colón-Otero
Journal:  Am J Hosp Palliat Care       Date:  2013-04-23       Impact factor: 2.500

Review 7.  Communication about cancer near the end of life.

Authors:  Anthony L Back; Wendy G Anderson; Lynn Bunch; Lisa A Marr; James A Wallace; Holly B Yang; Robert M Arnold
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

8.  The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives.

Authors:  Bhumsuk Keam; Young Ho Yun; Dae Seog Heo; Byeong Woo Park; Chi-Heum Cho; Sung Kim; Dae Ho Lee; Soon Nam Lee; Eun Sook Lee; Jung Hun Kang; Si-Young Kim; Jung Lim Lee; Chang Geol Lee; Yeun Keun Lim; Sam Yong Kim; Jong Soo Choi; Hyun Sik Jeong; Mison Chun
Journal:  Support Care Cancer       Date:  2012-12-22       Impact factor: 3.603

9.  End-of-Life Palliative Care Practices and Referrals in Uganda.

Authors:  Daniel Low; Emily C Merkel; Manoj Menon; Elizabeth Loggers; Henry Ddungu; Mhoira Leng; Elizabeth Namukwaya; Corey Casper
Journal:  J Palliat Med       Date:  2017-10-23       Impact factor: 2.947

10.  Physician factors associated with outpatient palliative care referral.

Authors:  S C Ahluwalia; T R Fried
Journal:  Palliat Med       Date:  2009-05-21       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.